Logo image of TR1.DE

T ROWE PRICE GROUP INC (TR1.DE) Stock Fundamental Analysis

FRA:TR1 - Deutsche Boerse Ag - US74144T1088 - Common Stock - Currency: EUR

83.88  +1.39 (+1.69%)

Fundamental Rating

7

Taking everything into account, TR1 scores 7 out of 10 in our fundamental rating. TR1 was compared to 114 industry peers in the Capital Markets industry. TR1 is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. TR1 is valued quite cheap, while showing a decent growth score. This is a good combination! Finally TR1 also has an excellent dividend rating. With these ratings, TR1 could be worth investigating further for value and dividend investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

TR1 had positive earnings in the past year.
TR1 had a positive operating cash flow in the past year.
In the past 5 years TR1 has always been profitable.
TR1 had a positive operating cash flow in each of the past 5 years.
TR1.DE Yearly Net Income VS EBIT VS OCF VS FCFTR1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

The Return On Assets of TR1 (14.04%) is better than 95.61% of its industry peers.
With an excellent Return On Equity value of 18.90%, TR1 belongs to the best of the industry, outperforming 87.72% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 14.17%, TR1 belongs to the top of the industry, outperforming 93.86% of the companies in the same industry.
TR1 had an Average Return On Invested Capital over the past 3 years of 15.27%. This is significantly above the industry average of 8.01%.
Industry RankSector Rank
ROA 14.04%
ROE 18.9%
ROIC 14.17%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
TR1.DE Yearly ROA, ROE, ROICTR1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

TR1's Profit Margin of 27.64% is fine compared to the rest of the industry. TR1 outperforms 77.19% of its industry peers.
In the last couple of years the Profit Margin of TR1 has declined.
With a decent Operating Margin value of 33.61%, TR1 is doing good in the industry, outperforming 77.19% of the companies in the same industry.
TR1's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 33.61%
PM (TTM) 27.64%
GM N/A
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
TR1.DE Yearly Profit, Operating, Gross MarginsTR1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

The number of shares outstanding for TR1 has been reduced compared to 1 year ago.
Compared to 5 years ago, TR1 has less shares outstanding
The debt/assets ratio for TR1 has been reduced compared to a year ago.
TR1.DE Yearly Shares OutstandingTR1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
TR1.DE Yearly Total Debt VS Total AssetsTR1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 5.79 indicates that TR1 is not in any danger for bankruptcy at the moment.
The Altman-Z score of TR1 (5.79) is better than 90.35% of its industry peers.
TR1 has a debt to FCF ratio of 0.03. This is a very positive value and a sign of high solvency as it would only need 0.03 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.03, TR1 belongs to the best of the industry, outperforming 98.25% of the companies in the same industry.
TR1 has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of TR1 (0.00) is better than 89.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Altman-Z 5.79
ROIC/WACCN/A
WACCN/A
TR1.DE Yearly LT Debt VS Equity VS FCFTR1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

TR1 has a Current Ratio of 2.61. This indicates that TR1 is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of TR1 (2.61) is better than 82.46% of its industry peers.
A Quick Ratio of 2.61 indicates that TR1 has no problem at all paying its short term obligations.
TR1 has a Quick ratio of 2.61. This is amongst the best in the industry. TR1 outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.61
Quick Ratio 2.61
TR1.DE Yearly Current Assets VS Current LiabilitesTR1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

TR1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.74%, which is quite good.
The Earnings Per Share has been growing slightly by 2.42% on average over the past years.
The Revenue has been growing slightly by 6.51% in the past year.
TR1 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.78% yearly.
EPS 1Y (TTM)10.74%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%-6.3%
Revenue 1Y (TTM)6.51%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%0.78%

3.2 Future

TR1 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.59% yearly.
TR1 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.79% yearly.
EPS Next Y-10.03%
EPS Next 2Y-3.99%
EPS Next 3Y-1.81%
EPS Next 5Y3.59%
Revenue Next Year-2.61%
Revenue Next 2Y0.03%
Revenue Next 3Y1.1%
Revenue Next 5Y2.79%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TR1.DE Yearly Revenue VS EstimatesTR1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
TR1.DE Yearly EPS VS EstimatesTR1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

TR1 is valuated reasonably with a Price/Earnings ratio of 10.38.
TR1's Price/Earnings ratio is rather cheap when compared to the industry. TR1 is cheaper than 84.21% of the companies in the same industry.
TR1's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.35.
TR1 is valuated reasonably with a Price/Forward Earnings ratio of 11.07.
Based on the Price/Forward Earnings ratio, TR1 is valued cheaper than 81.58% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.20, TR1 is valued rather cheaply.
Industry RankSector Rank
PE 10.38
Fwd PE 11.07
TR1.DE Price Earnings VS Forward Price EarningsTR1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

85.96% of the companies in the same industry are more expensive than TR1, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of TR1 indicates a rather cheap valuation: TR1 is cheaper than 80.70% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.42
EV/EBITDA 6.87
TR1.DE Per share dataTR1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The decent profitability rating of TR1 may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.3
EPS Next 2Y-3.99%
EPS Next 3Y-1.81%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.34%, TR1 is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.98, TR1 pays a better dividend. On top of this TR1 pays more dividend than 86.84% of the companies listed in the same industry.
TR1's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 5.34%

5.2 History

The dividend of TR1 is nicely growing with an annual growth rate of 10.37%!
Dividend Growth(5Y)10.37%
Div Incr Years2
Div Non Decr Years2
TR1.DE Yearly Dividends per shareTR1.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

TR1 pays out 57.96% of its income as dividend. This is a bit on the high side, but may be sustainable.
TR1's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP57.96%
EPS Next 2Y-3.99%
EPS Next 3Y-1.81%
TR1.DE Yearly Income VS Free CF VS DividendTR1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
TR1.DE Dividend Payout.TR1.DE Dividend Payout, showing the Payout Ratio.TR1.DE Dividend Payout.PayoutRetained Earnings

T ROWE PRICE GROUP INC

FRA:TR1 (5/27/2025, 7:00:00 PM)

83.88

+1.39 (+1.69%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-24 2025-07-24/amc
Inst Owners79.04%
Inst Owner ChangeN/A
Ins Owners1.67%
Ins Owner ChangeN/A
Market Cap18.48B
Analysts50
Price Target83.08 (-0.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.34%
Yearly Dividend4.5
Dividend Growth(5Y)10.37%
DP57.96%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.33%
Min EPS beat(2)-5.31%
Max EPS beat(2)2.66%
EPS beat(4)2
Avg EPS beat(4)0.76%
Min EPS beat(4)-5.31%
Max EPS beat(4)7.98%
EPS beat(8)6
Avg EPS beat(8)7.08%
EPS beat(12)9
Avg EPS beat(12)3.35%
EPS beat(16)10
Avg EPS beat(16)1.9%
Revenue beat(2)0
Avg Revenue beat(2)-3.65%
Min Revenue beat(2)-4.33%
Max Revenue beat(2)-2.98%
Revenue beat(4)0
Avg Revenue beat(4)-4.31%
Min Revenue beat(4)-5.13%
Max Revenue beat(4)-2.98%
Revenue beat(8)2
Avg Revenue beat(8)-2.39%
Revenue beat(12)3
Avg Revenue beat(12)-2.9%
Revenue beat(16)3
Avg Revenue beat(16)-2.69%
PT rev (1m)-16.8%
PT rev (3m)-22.76%
EPS NQ rev (1m)-6.51%
EPS NQ rev (3m)-13.05%
EPS NY rev (1m)-4.2%
EPS NY rev (3m)-10.86%
Revenue NQ rev (1m)-4.62%
Revenue NQ rev (3m)-7.2%
Revenue NY rev (1m)-1.66%
Revenue NY rev (3m)-6.57%
Valuation
Industry RankSector Rank
PE 10.38
Fwd PE 11.07
P/S 2.95
P/FCF 16.42
P/OCF 12.48
P/B 2.02
P/tB 2.83
EV/EBITDA 6.87
EPS(TTM)8.08
EY9.63%
EPS(NY)7.57
Fwd EY9.03%
FCF(TTM)5.11
FCFY6.09%
OCF(TTM)6.72
OCFY8.01%
SpS28.41
BVpS41.55
TBVpS29.61
PEG (NY)N/A
PEG (5Y)4.3
Profitability
Industry RankSector Rank
ROA 14.04%
ROE 18.9%
ROCE 19.03%
ROIC 14.17%
ROICexc 18.29%
ROICexgc 29.81%
OM 33.61%
PM (TTM) 27.64%
GM N/A
FCFM 17.99%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
ROICexc(3y)18.71%
ROICexc(5y)21.89%
ROICexgc(3y)30.22%
ROICexgc(5y)33.06%
ROCE(3y)20.58%
ROCE(5y)24.24%
ROICexcg growth 3Y-16.2%
ROICexcg growth 5Y-1.08%
ROICexc growth 3Y-13.37%
ROICexc growth 5Y-6.73%
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Debt/EBITDA 0.02
Cap/Depr 157.94%
Cap/Sales 5.67%
Interest Coverage 250
Cash Conversion 63.6%
Profit Quality 65.07%
Current Ratio 2.61
Quick Ratio 2.61
Altman-Z 5.79
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)130.91%
Cap/Depr(5y)124.54%
Cap/Sales(3y)4.8%
Cap/Sales(5y)4.19%
Profit Quality(3y)84.47%
Profit Quality(5y)86.86%
High Growth Momentum
Growth
EPS 1Y (TTM)10.74%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%-6.3%
EPS Next Y-10.03%
EPS Next 2Y-3.99%
EPS Next 3Y-1.81%
EPS Next 5Y3.59%
Revenue 1Y (TTM)6.51%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%0.78%
Revenue Next Year-2.61%
Revenue Next 2Y0.03%
Revenue Next 3Y1.1%
Revenue Next 5Y2.79%
EBIT growth 1Y11.46%
EBIT growth 3Y-13.78%
EBIT growth 5Y-0.07%
EBIT Next Year-6.5%
EBIT Next 3Y0.33%
EBIT Next 5Y4.53%
FCF growth 1Y-16.14%
FCF growth 3Y-26.76%
FCF growth 5Y-0.86%
OCF growth 1Y-4.89%
OCF growth 3Y-21.25%
OCF growth 5Y2.05%